CAR-T Therapy LYL273 Advances to Phase 1/2 in Colorectal Cancer
The amendment signals regulatory confidence in next-generation cell therapy manufacturing as solid-tumor CAR-T programs…
The amendment signals regulatory confidence in next-generation cell therapy manufacturing as solid-tumor CAR-T programs…
The readout covers tolerability, receptor occupancy, and immunogenicity endpoints — key signals for a mechanism with po…
Real-world evidence from a matched Medicare cohort signals a meaningful care-pathway shift for lumbar discogenic pain m…
The oral presentation marks a clinical milestone for polyclonal antibody therapies targeting post-transplant viral comp…
Automated CLIA platforms are reshaping how nutraceutical and functional food efficacy claims are validated at the clini…
An R&D Spotlight planned for late summer is expected to outline next-stage development milestones for the investigation…
Health systems leaning on telehealth infrastructure could accelerate practitioner-channel nutraceutical recommendations…